Alexopoulos A, Karanikiotis C, Ardavanis A, Boukovinas I, et al. Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 "MELPOMENI" s Anticancer Res 2022;42:1031-1041.
PMID: 35093904